How do you transition pediatric or adult patients who may already be on other systemic agents such as cyclosporine or methotrexate to dupilumab? Can you provide practical guidance that is applicable to the front lines of AD care?

How do you transition pediatric or adult patients who may already be on other systemic agents such as cyclosporine or methotrexate to dupilumab? Can you provide practical guidance that is applicable to the front lines of AD care?

How do you transition pediatric or adult patients who may already be on other systemic agents such as cyclosporine or methotrexate to dupilumab? Can you provide practical guidance that is applicable to the front lines of AD care?


Created by

CMEducation Resources iQ&A Case-By-Case Atopic Dermatitis Medical Intelligence Zone

Presenter

Mark Lebwohl, MD

Mark Lebwohl, MD

Professor and Chairman, Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, New York USA